AI-generated summary
This retrospective cohort study of 75 melasma patients compared a pure pigmentary type with a mixed pigmentary-vascular type, all treated with a low-fluence 1064 nm Q-switched laser plus oral tranexamic acid. The authors report that the mixed type had significantly lower mMASI reduction and higher treatment resistance, with the difference most pronounced in severe disease. The study is retrospective and observational, so these associations cannot establish cause.
- Participants
- 75
- Who or what was studied
- Adults with melasma, stratified by severity (mild, moderate, severe) and classified as pure pigmentary (n = 42) or mixed pigmentary-vascular (n = 33)
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- Retrospective, single-cohort design with no control group, so associations cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Primary outcome, Heterogeneity, Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.